Chantix Settlement Amount | Chantix Multidistrict Litigation

Chantix Multidistrict Litigation May Lead To Settlements

Sasha Colter | February 16th, 2011

The assignment of over a thousand cases to a Chantix multidistrict litigation court should result in an expeditious ruling complete with a Chantix settlement amount. Chantix is a prescription drug manufactured by Pfizer to aid individuals as they try to stop smoking. Plaintiffs in Chantix multidistrict litigation allege that Pfizer designed, manufactured, tested, marketed, sold, distributed and promoted Chantix, while minimizing the side effects of the drug.

Chantix has been effective in aiding individuals as they quit smoking. It has also been linked to the following side effects: behavioral changes, depression, agitation, rage, suicidal ideation, aggression, hostility, suicide attempts and suicide. It is also alleged that Chantix is associated with seizures, heart rhythm disturbances, muscle disorders, diabetes, vision disturbances, and loss of consciousness.

Multidistrict litigation panel centralizes Chantix cases

The Multidistrict Litigation Judicial Panel identified the need to centralize the Chantix cases due to common questions of fact. As of this week, approximately 1,200 Chantix lawsuits have been consolidated. It is estimated that this number will continue to rise. The Northern District of Alabama was identified as an appropriate forum for the litigation. Chantix Multidistrict Litigation is handled by the Honorable Inge P. Johnson. Chantix Multidistrict Litigation will coordinate discovery in addition to handling any other pretrial matters as appropriate. Once these are concluded the cases could be transferred to the district in which they were originally filed for further proceedings.

Chantix settlement amount subject of speculation

Speculation on Chantix settlement amounts continues as the number of cases filed escalates. Similar case suits against large pharmaceutical companies have resulted in pre-trial settlement for substantial amounts of money in accordance with the severity of the side effects and the temporary or permanent nature of those side effects. If Chantix settlement amounts are not agreed upon pre-trial the first cases will most likely end up in trial sometime in 2012. But in multidistrict litigation it is common for defendants to reach settlements with most plaintiffs before the suit goes to trial. A safe estimate of Chantix settlement amounts is that they could total more than a billion dollars.

As of a statement released on January 7, 2011, Pfizer maintains that the development and marketing of Chantix was handled appropriately.